Hasan Ahmad Hasan Albitar

An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study

Hanny Al‐Samkari, Raj S. Kasthuri, Joseph G. Parambil et al. · Haematologica · 2020 · 136 citations · Full text

Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers

Hanny Al‐Samkari, Hasan Ahmad Hasan Albitar, Scott E. Olitsky et al. · Orphanet Journal of Rare Diseases · 2019 · 41 citations · Full text

Intravenous Bevacizumab Reduces Transfusion Requirements and Endoscopic Interventions in Patients With Gastric Antral Vascular Ectasia and Small Bowel Angioectasia

Hasan Ahmad Hasan Albitar, Yahya Almodallal, Konstantinos Papadakis et al. · Gastroenterology · 2019 · 40 citations

Endoscopic Interventions, Gastroenterology, Vascular Surgery +7

An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia

Hanny Al‐Samkari, Hasan Ahmad Hasan Albitar, Scott E. Olitsky et al. · Haemophilia · 2020 · 26 citations

Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding

Rabea Asleh, Hasan Ahmad Hasan Albitar, Sarah Schettle et al. · The Journal of Heart and Lung Transplantation · 2020 · 15 citations

Heart Failure, Cardiac Anaesthesia, Cardiovascular Disease +6